Elevance Health (ELV) Q3 Earnings Lag Estimates - TradingView

Elevance Health (ELV) came out with quarterly earnings of $8.37 per share, missing the Zacks Consensus Estimate of $9.70 per share. This compares to earnings of $8.99 per share a year …

$8.37
OFF

Elevance Health (ELV) Q3 Earnings Lag Estimates - TradingView

2 weeks from now

Elevance Health (ELV) came out with quarterly earnings of $8.37 per share, missing the Zacks Consensus Estimate of $9.70 per share. This compares to earnings of $8.99 per share a year …

tradingview.com

71%
OFF

Elevance Health (ELV) Q3 Earnings Lag Estimates

2 weeks from now

Oct 17, 2024 · Elevance Health (ELV) delivered earnings and revenue surprises of -13.71% and 3.37%, respectively, for the quarter ended September 2024. Do the numbers hold clues to …

zacks.com

$8.37
OFF

Elevance Health (ELV) Q3 Earnings Lag Estimates - Nasdaq

2 weeks from now

Oct 17, 2024 · Elevance Health (ELV) came out with quarterly earnings of $8.37 per share, missing the Zacks Consensus Estimate of $9.70 per share. This compares to earnings of …

nasdaq.com

3%
OFF

These Analysts Cut Their Forecasts On Elevance Health Following …

2 weeks from now

Oct 18, 2024 · Elevance Health Inc. NYSE:ELV reported weaker-than-expected earnings for its third quarter on Thursday.The company posted revenues of $44.7 billion, up 5.3% year-over …

tradingview.com

$8.37
OFF

Elevance Health (ELV) To Release Earnings On Thursday - MarketBeat

2 weeks from now

6 hours ago · Elevance Health (NYSE:ELV - Get Free Report) last issued its earnings results on Thursday, October 17th. The company reported $8.37 earnings per share for the quarter, …

marketbeat.com

3%
OFF

Compared To Estimates, Elevance Health (ELV) Q3 Earnings: A

2 weeks from now

Oct 17, 2024 · For the quarter ended September 2024, Elevance Health (ELV) reported revenue of $44.72 billion, up 5.3% over the same period last year. EPS came in at $8.37, compared to …

nasdaq.com

3%
OFF

Elevance Health's Q3 Earnings: Profit Falls Short Of ... - Benzinga

2 weeks from now

Oct 17, 2024 · Elevance Health Q3 revenue rose 5.3% YoY to $44.7 billion, above the consensus estimate of $43.33 billion. Profit declined 21% to $1.02 billion, with adjusted EPS of $8.37 …

benzinga.com

$500
OFF

Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry ...

2 weeks from now

Oct 17, 2024 · Investment Overview. Elevance Health (NYSE:ELV) reported its Q3 earnings today, and its stock price has taken a tumble, falling from ~$500 per share, to ~$430 per share …

seekingalpha.com

$10.12
OFF

Will Elevance Health (ELV) Beat Estimates Again In Its Next …

2 weeks from now

Oct 16, 2024 · For the last reported quarter, Elevance Health came out with earnings of $10.12 per share versus the Zacks Consensus Estimate of $9.99 per share, representing a surprise of …

nasdaq.com

FAQs about Elevance Health (ELV) Q3 Earnings Lag Estimates - TradingView Coupon?

Should you buy Elevance health (ELV)?

Given the current market conditions, I recommend a "hold" rating for Elevance, with no compelling reason to buy at this time. Elevance Health (NYSE: ELV) reported its Q3 earnings today, and its stock price has taken a tumble, falling from ~$500 per share, to ~$430 per share - a drop of ~14%. ...

Why did Elevance health stock drop 4% in Q3?

Elevance Health's Q3 earnings report led to a 14% stock price drop due to increased benefit expense ratio and declining EPS. The health insurance industry faces challenges, particularly in Medicare Advantage and Medicaid, affecting profitability and causing industry-wide share price declines. ...

Why did Elevance Miss analysts' expectations in Q3?

There is a second major reason why Elevance missed analysts' expectations in Q3, however, which relates to its Medicaid business - which is, in fact, larger than its MA business in terms of revenue generation. In its earnings press release, management refers to a "timing mismatch between Medicaid rates and the higher acuity of our members". ...

How many times has Elevance health surpassed consensus EPS estimates?

Over the last four quarters, the company has surpassed consensus EPS estimates three times. Elevance Health , which belongs to the Zacks Medical Services industry, posted revenues of $44.72 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 3.37%. This compares to year-ago revenues of $42.48 billion. ...

Is Elevance stock a'sell'?

Back in April this year, in a note for Seeking Alpha I gave Elevance stock a "sell" rating - becoming the first SA analyst ever to do so, I believe - and while the stock price is now down ~15% since that note, I have to admit my thesis does not exactly tally with how things have panned out. ...